Author

J. A. Greenbaum

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 4 Organism:human· 4 Approach:experimental assay· 3 Assay:proteomics· 3 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1

Frequent Co-Authors

B. Peters· 4 shared A. Sette· 3 shared D. Weiskopf· 2 shared R. da Silva Antunes· 2 shared A. Crinklaw· 1 shared A. D. deSilva· 1 shared A. Frazier· 1 shared A. Grifoni· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

B. Peters

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression

J. S. Dolina, J. Lee, S. E. Brightman, S. McArdle, S. M. Hall, R. R. Thota, M. Lanka, A. L. R. Premlal, J. A. Greenbaum, E. E. W. Cohen, B. Peters, S. P. Schoenberger

This study shows that combining CD4+/CD8+ T cell neoantigen vaccination with immune checkpoint blockade overcomes resistance and enables tumor regression in low TMB cancers.

bioRxiv · May 6, 2023 · PreprintImmunology

TCRMatch: Predicting T-cell receptor specificity based on sequence similarity to previously characterized receptors

W. D. Chronister, A. Crinklaw, S. Mahajan, R. Vita, Z. Kosaloglu-Yalcin, Z. Yan, J. A. Greenbaum, L. E. Jessen, M. Nielsen, S. Christley, L. G. Cowell, A. Sette, B. Peters

TCRMatch predicts T-cell receptor specificity by comparing sequence similarity to known epitope-specific receptors in the IEDB.

bioRxiv · Dec 11, 2020Immunology

Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases

A. Tarke, J. Sidney, C. K. Kidd, J. M. Dan, S. I. Ramirez, E. D. Yu, J. Mateus, R. da Silva Antunes, E. Moore, P. Rubiro, N. Methot, E. J. Phillips, S. Mallal, A. Frazier, S. Rawlings, , A. Sette

The paper identifies SARS-CoV-2 epitopes recognized by CD4+ and CD8+ T cells in COVID-19 patients and develops epitope megapools for their detection.

bioRxiv · Dec 8, 2020Immunology

No cell is an island: circulating T cell:monocyte complexes are markers of immune perturbations

J. G. Burel, M. Pomaznoy, C. S. Lindestam Arlehamn, D. Weiskopf, R. da Silva Antunes, Y. Jung, V. Schulten, M. Babor, G. Seumois, J. A. Greenbaum, S. Premawansa, G. Premawansa, A. Wijewickrama, D. Vidanagama, B. Gunasena, , B. Peters

The paper identifies T cell:monocyte complexes in human blood as biological immune interactions, not technical artifacts, and shows their frequency changes with immune perturbations.

bioRxiv · Feb 21, 2019 · PreprintImmunology